Brinker Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $1.9M | Sell |
15,577
-74
| -0.5% | -$9.03K | 0.06% | 312 |
|
|
2020
Q1 | $1.36M | Buy |
15,651
+3,456
| +28% | +$299K | 0.05% | 333 |
|
|
2019
Q4 | $1.31M | Buy |
12,195
+89
| +0.7% | +$9.57K | 0.04% | 419 |
|
|
2019
Q3 | $1.09M | Buy |
12,106
+1,703
| +16% | +$153K | 0.04% | 459 |
|
|
2019
Q2 | $878K | Buy |
10,403
+51
| +0.5% | +$4.3K | 0.03% | 521 |
|
|
2019
Q1 | $912K | Buy |
10,352
+483
| +5% | +$42.6K | 0.03% | 492 |
|
|
2018
Q4 | $705K | Buy |
+9,869
| New | +$705K | 0.03% | 506 |
|